Diagnostic Test
X PRIZE to help fight tuberculosis with Gates FoundationThe X PRIZE Foundation has received a planning grant from the Bill & Melinda Gates Foundation to develop an X PRIZE for effective diagnosis of tuberculosis in the developing world.
$19 Million to M. D. Anderson for breast cancer researchThe University of Texas M. D. Anderson Cancer Center has received nearly $19 million in grants from Susan G. Komen for the Cure® as part of that organization's new initiative to fast-track promising research to benefit breast cancer patients.
QIAGEN's careHPV test provides more accurate screeningA new HPV test developed by QIAGEN specifically for use in regions of the world with scarce resources is "substantially" more accurate in identifying women with cervical disease than the current methods (Pap testing and visual inspection) in these countries.
HIV people not tested for tuberculosisA mere 1% of people living with HIV/AIDS are reported to have been screened for TB, according to the most recent global data available from the World Health Organization. Health experts and activists at the International AIDS Conference are calling upon HIV/AIDS programs and international donors to ensure universal TB screening of every person who has tested positive for HIV.
HIV risk high in indian women abused by husbandsMarried women in India who experience physical and sexual violence from their husbands have an increased risk of HIV infection, compared with women who are not abused by their husbands, according to a study in the August 13 issue of JAMA, a theme issue on violence and human rights.
VereFlu portable lab-on-chip for detection of bird fluFollowing the success of the evaluation trials conducted at the prestigious National University Hospital of Singapore, Veredus Laboratories and STMicroelectronics (NYSE: STM) announced the commercial availability of VereFlu, a portable lab-on-chip application for rapid detection of all major influenza types at the point of need.
Colorectal cancer screening guidelines updateA new guideline on colorectal cancer screening released by an expert group representing a broad spectrum of health care organizations, including the American College of Gastroenterology (ACG), the American Society for Gastrointestinal Endoscopy (ASGE) and the American Cancer Society (ACS), offers recommendations for various alternatives for colorectal cancer detection and states a strong preference for screening tests that can prevent colorectal cancer.
Quest Diagnostics & Google provide patients electronic access to their diagnostic laboratory dataUS patients may soon have easy and secure access to their own medical diagnostic laboratory records as a result of a new collaboration between Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, and Google, the world's leading Internet search company.
New chemical tool kit reveals insights into drug toxicityWhy do nearly 1 million people taking cholesterol-lowering statins often experience muscle cramps? Why is it that in the rare case when a diabetic takes medication for intestinal worms, his glucose levels improve? Is there any scientific basis for the purported health effects of green tea?
21% errors in pathology reports in Miramichi Hospital, New BrunswickAn additional review of pathology reports in Miramichi Hospital, New Brunswick is completed by Dr. Rosemary Henderson, pathologist. This review included 227 cases of prostate and breast cancer biopsies from 2004-2005. The results indicated that 18 percent of the cases had incomplete results and three percent of the cases were misdiagnosed.
7 new prostate cancer genetic risk factors identified7 new sites in the human genome identified that are linked to men's risk of developing prostate cancer, revealed by Cancer Research UK funded scientists at the Institute of Cancer Research and University of Cambridge.
Simple urine test detecting prostate cancer accuratelyAn experimental biomarker test developed by researchers at the University of Michigan more accurately detects prostate cancer than any other screening method currently in use, according to a study published in the February 1 issue of Cancer Research, a journal of the American Association for Cancer Research.
Abbott to educate Chicago-area women about heart diseaseAs a leader in cardiovascular treatment and the exclusive Chicagoland "hometown" partner for the national "Go Red for Women" program, Abbott is partnering with the American Heart Association (AHA) to raise awareness about heart disease, the leading cause of death for women in America.
Studies highlight MRSA evolution and resilienceCommunity-associated methicillin-resistant Staphylococcus aureus (CA-MRSA) infections are caused primarily by a single strain-USA300-of an evolving bacterium that has spread with "extraordinary transmissibility" throughout the United States during the past five years, according to a new study led by National Institutes of Health (NIH) scientists. CA-MRSA, an emerging public health concern, typically causes readily treatable soft-tissue infections such as boils, but also can lead to life-threatening conditions that are difficult to treat.
Prodesse's ProFlu+ Test for Respiratory Viruses receives FDA clearanceProdesse, Inc., the leader in multiplex real-time PCR for infectious disease, announced that it received clearance from the U.S. Food and Drug Administration (FDA) to market its ProFlu+™ Assay.
Strong health system in Canada by 2020, says CNABy 2020, problems with access to health services will be eradicated and registered nurses will be central to Canada's primary care system, predicts the Canadian Nurses Association (CNA) in Vision for Change a vision statement for Canada's health system and a signature component of their 100th anniversary.
New test to detect and identify 12 respiratory virusesThe U.S. Food and Drug Administration has approved a new diagnostic test that detects 12 respiratory viruses, including strains of flu that have triggered epidemics.
MRI for better assessment of liver fibrosisMRI imagery is emerging as a non-invasive way to determine the existence and extent of hepatic fibrosis. It could eventually help the development of pharmacologic strategies to combat the condition.
New screening strategy for detection of chagas diseaseA new targeted screening strategy could make the diagnosis and treatment of Chagas disease more feasible in low-resource settings, concludes a new study, publishing on December 26, 2007, in the open-access journal PLoS Neglected Tropical Diseases.